Trials / Completed
CompletedNCT02955706
Assessment the Efficacy of Acetyl-L-carnitine in Patient With Alzheimer's Disease
A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial to Assess the Efficacy of Acetyl-L-carnitine in Patient With Alzheimer's Disease
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 265 (actual)
- Sponsor
- Dong-A ST Co., Ltd. · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
clinical trial to assess the efficacy of Acetyl-L-carnitine
Detailed description
A multicenter, randomized, double-blind, placebo-controlled clinical trial to assess the efficacy of Acetyl-L-carnitine in patient with Alzheimer's disease
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Acetyl-L-Carnitine | TID |
| DRUG | Placebo of Acetyl-L-Carnitine | TID |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2018-09-29
- Completion
- 2019-01-25
- First posted
- 2016-11-04
- Last updated
- 2021-04-14
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02955706. Inclusion in this directory is not an endorsement.